Tristar Wellness(TWSI)
USD --+0.00%
Reward31Low
Risk47Moderate
📊75%Data
Thin -177% profit margin · Revenue down 50% YoY
TWSI
+0.0 · +0.00%
USD · PINK
Tristar Wellness | Healthcare
Earnings Deterioration
Market Cap:6.07M
ℹ️
Reward Rating
31
Low
Bottom 1% (model universe)
75% data coverage
ℹ️
Risk Rating
47
Moderate
Risk Assessment
75% data coverage
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on TWSI to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Tristar Wellness?

engages in the development, marketing, and sale of wound care products.

TWSI · Verdict

Limited reward · moderate risk

TWSI's standout is balance sheet; volatility and profitability weigh on the picture.

Based on 75% data coverage

TWSI · Verdict

What’s working & what to watch

Strengths 1

  • Balance sheet100/100

    Top decile vs peers

Watchouts 3

  • Volatility5/100

    Weak vs peers

  • Profitability10/100

    0% return on equity

  • Growth18/100

    Earnings -88.7% CAGR

Model-based scoring. For information only — not financial advice.

What is Tristar Wellness?

engages in the development, marketing, and sale of wound care products. The company offers skincare and other products under the Beaute de Maman name for pregnant and nursing women; bleeding and wound management products for surgical, health care, consumer, and military markets; and develops and markets Delivery Devise with Invertible Diaphragm, which is a medical applicator for delivering medicants and internal devices within the body without producing injury or damage. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 6.07M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Low (31)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap6.07M
P/E RatioN/A
Dividend YieldN/A
52 Week High0.29
52 Week Low0.031
Last AnnualDecember
IPO Date7/22/1999
IncorporatedUSA
Shares Outstanding88M
No. of Employees35
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta14.099
CurrencyUSD